BETWEENLicense Agreement • March 16th, 2000 • Supergen Inc • Pharmaceutical preparations • Nevada
EXHIBIT 4.6 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (the "Agreement") is made and entered into as of this 27th day of September, 2000 by and between Supergen, Inc., a Delaware corporation (the "Company"), and the "Seller"...Registration Rights Agreement • December 20th, 2000 • Supergen Inc • Pharmaceutical preparations • Delaware
WITNESSETH:Purchase and Sale Agreement • October 15th, 1996 • Supergen Inc • Pharmaceutical preparations • Delaware
COMMON STOCKUnderwriting Agreement • March 16th, 2000 • Supergen Inc • Pharmaceutical preparations • New York
EXHIBIT 10.26 [*] REDACTED CONFIDENTIAL TREATMENT REQUESTED NON-EXCLUSIVE SUPPLY AGREEMENT THIS AGREEMENT ENTERED INTO by and between [*] (hereinafter "[*]") with its principal offices located at [*] and SuperGen, Inc. (hereinafter "SuperGen") with...Supply Agreement • May 15th, 1997 • Supergen Inc • Pharmaceutical preparations • California
WITNESSETH:Confidential Treatment • January 21st, 2000 • Supergen Inc • Pharmaceutical preparations • Nevada
CONFIDENTIAL TREATMENT REQUESTED * Portions denoted with an asterisk have been omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment. WORLDWIDE SALES, DISTRIBUTION, AND DEVELOPMENT...Development Agreement • March 16th, 2000 • Supergen Inc • Pharmaceutical preparations • Illinois
EXHIBIT 10.33 STANDARD INDUSTRIAL/COMMERCIAL MULTI-TENANT LEASE -- GROSS, AMERICAN INDUSTRIAL REAL ESTATE ASSOCIATION 1. BASIC PROVISIONS ("BASIC PROVISIONS"). 1.1 PARTIES: This Lease ("LEASE"), dated for reference purposes only, February 12 , 1999,...Supergen Inc • March 31st, 1999 • Pharmaceutical preparations
EXHIBIT 4.1 SUPERGEN, INC. TWO ANNABEL LANE, SUITE 220 SAN RAMON, CALIFORNIA 94583 AVI BIOPHARMA, INC. ONE SW COLUMBIA, SUITE 1105 PORTLAND, OR 97258 REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 20th, 2000 • Supergen Inc • Pharmaceutical preparations • Delaware
RECITALSAssignment and Assumption Agreement • May 15th, 1997 • Supergen Inc • Pharmaceutical preparations
W I T N E S S E T H:Registration Rights Agreement • March 31st, 1999 • Supergen Inc • Pharmaceutical preparations • Delaware
RECITALSRegistration Rights Agreement • January 21st, 2000 • Supergen Inc • Pharmaceutical preparations • Delaware
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 10th, 2004 • Supergen Inc • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is made and entered into as of March 5, 2004, by and among SuperGen, Inc., a Delaware corporation (the “Company”), and the purchasers signatory hereto (each such purchaser, a “Purchaser” and collectively, the “Purchasers”).
BACKGROUNDAsset Purchase Agreement • March 23rd, 2001 • Supergen Inc • Pharmaceutical preparations • California
BACKGROUNDStock Purchase Agreement • March 31st, 1999 • Supergen Inc • Pharmaceutical preparations • California
Exhibit 10.22 REDACTED CONFIDENTIAL TREATMENT REQUESTED ASSET PURCHASE AGREEMENT This ASSET PURCHASE AGREEMENT is made and entered into as of January 15, 1997 (the "Agreement") by and between Immunex Corporation, a Washington corporation ("Immunex"),...Asset Purchase Agreement • March 31st, 1997 • Supergen Inc • Pharmaceutical preparations • California
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 1st, 2002 • Supergen Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of September 23, 2002, among SuperGen, Inc., a Delaware corporation (the “Company”), and the purchasers identified on the signature pages hereto (each a “Purchaser” and collectively the “Purchasers”).
W I T N E S S E T H:Registration Rights Agreement • May 14th, 1999 • Supergen Inc • Pharmaceutical preparations • Delaware
EXHIBIT 10.59 UNITED STATES OF AMERICA SALES, DISTRIBUTION, AND DEVELOPMENT AGREEMENT This Sales, Distribution, and Development Agreement (the "Agreement") is made as of April 4, 2000 (the "Effective Date") by and between AVI BioPharma, Inc., ("AVI"),...And Development Agreement • March 23rd, 2001 • Supergen Inc • Pharmaceutical preparations • Delaware
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 25th, 2003 • Supergen Inc • Pharmaceutical preparations • New York
SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of June 24, 2003 by and among SuperGen, Inc., a Delaware corporation, with headquarters located at 4140 Dublin Boulevard, Suite 200, Dublin, California 94568 (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
CONFIDENTIAL TREATMENT REQUESTED * Portions denoted with an asterisk have been omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment. U.S. DISTRIBUTION AGREEMENT This U.S....Distribution Agreement • March 16th, 2000 • Supergen Inc • Pharmaceutical preparations • Illinois
December 11, 1996 (Date for Reference Purposes)Offer, Agreement • March 31st, 1997 • Supergen Inc • Pharmaceutical preparations
AGREEMENT AND PLAN OF MERGER by and among OTSUKA PHARMACEUTICAL CO., LTD., AUTUMN ACQUISITION CORPORATION and ASTEX PHARMACEUTICALS, INC. Dated as of September 5, 2013Agreement and Plan of Merger • September 5th, 2013 • Astex Pharmaceuticals, Inc • Pharmaceutical preparations • Delaware
THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of September 5, 2013 by and among OTSUKA PHARMACEUTICAL CO., LTD., a Japanese joint stock company (“Parent”), AUTUMN ACQUISITION CORPORATION, a Delaware corporation and a direct or indirect, wholly-owned subsidiary of Parent (“Acquisition Sub”), and ASTEX PHARMACEUTICALS, INC., a Delaware corporation (the “Company”).
SUPPLY AGREEMENT between SUPERGEN, INC. andSupply Agreement • October 31st, 1997 • Supergen Inc • Pharmaceutical preparations • Delaware
RECITALSLicense Agreement • October 6th, 1997 • Supergen Inc • Pharmaceutical preparations • New York
WARRANT AGREEMENT BETWEEN SUPERGEN, INC. ANDWarrant Agreement • July 2nd, 1999 • Supergen Inc • Pharmaceutical preparations • California
AGREEMENT TO TERMINATE AND RELEASE OF COLLATERAL This Agreement to Terminate and Release of Collateral ("Release") dated this 30th day of September, 1999 is made by and between SuperGen, Inc., a Delaware corporation ("SuperGen") and TAKO Ventures,...Agreement • November 15th, 1999 • Supergen Inc • Pharmaceutical preparations • California
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 27th, 2003 • Supergen Inc • Pharmaceutical preparations • New York
SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February 26, 2003 by and among SuperGen, Inc., a Delaware corporation, with headquarters located at 4140 Dublin Boulevard, Suite 200, Dublin, California 94568 (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
Exhibit 2.1 AGREEMENT AND PLAN OF REORGANIZATION BY AND AMONG SUPERGEN, INC. ROYALE ACQUISITION CORP. AND SPARTA PHARMACEUTICALS, INC. DATED AS OF JANUARY 18, 1999 TABLE OF CONTENTSAgreement and Plan of Reorganization • January 28th, 1999 • Supergen Inc • Pharmaceutical preparations • Delaware
EXHIBIT 10.25 [*] REDACTED CONFIDENTIAL TREATMENT REQUESTED LICENSE AGREEMENTLicense Agreement • May 15th, 1997 • Supergen Inc • Pharmaceutical preparations • California
FORM OF SUBSCRIPTION AGREEMENTForm of Subscription Agreement • March 26th, 2012 • Astex Pharmaceuticals, Inc • Pharmaceutical preparations • New York
o A. Delivery by crediting the account of the Investor’s prime broker (as specified by such Investor on Exhibit A annexed hereto) through the Depository Trust Company’s (“DTC”) Deposit/Withdrawal At Custodian (“DWAC”) system, whereby Investor’s prime broker shall initiate a DWAC transaction on the Closing Date using its DTC participant identification number, and the Shares are released by [insert name of transfer agent], the Company’s transfer agent (the “Transfer Agent”), at the Company’s direction. NO LATER THAN ONE (1) BUSINESS DAY AFTER THE EXECUTION OF THIS AGREEMENT BY THE INVESTOR AND THE COMPANY, THE INVESTOR SHALL:
SUPERGEN, INC. EXECUTIVE EMPLOYMENT AND CONFIDENTIAL INFORMATION AND INVENTION ASSIGNMENT AGREEMENTExecutive Employment and Confidential Information and Invention Assignment Agreement • March 4th, 2004 • Supergen Inc • Pharmaceutical preparations • California
This Executive Employment and Confidential Information and Invention Assignment Agreement (the “Agreement”) is made and entered into as of January 1, 2004 (the “Effective Date”) by and between SuperGen, Inc., a Delaware corporation (the “Company”), and James S. Manuso (“Executive”).
REPLACEMENT OPTION AGREEMENT relating to the Astex Technology Limited Enterprise Management Incentive Share Scheme 2002Replacement Option Agreement • July 25th, 2011 • Supergen Inc • Pharmaceutical preparations
THIS CONFIDENTIALITY AND PROPRIETARY INFORMATION DEED is made the 22nd day of June 2012 BETWEEN: AGREED TERMSAstex Pharmaceuticals, Inc • June 28th, 2012 • Pharmaceutical preparations
The Executive is to be offered employment with or is engaged in employment with the Company and in consideration of his remuneration and benefits from time to time and an additional £1, the Executive has agreed as follows:
TERMINATION AND RELEASE AGREEMENTTermination and Release Agreement • March 7th, 2002 • Supergen Inc • Pharmaceutical preparations • Illinois
This Termination and Release Agreement (this "Agreement") dated as of March 4, 2002 (the "Effective Date") is entered into by and between SuperGen, Inc. ("SuperGen"), a California corporation with a principal office at 4140 Dublin Boulevard, Suite 200, Dublin, California 94568, and Abbott Laboratories ("Abbott"), an Illinois corporation with a principal office at 100 Abbott Park Road, Abbott Park, Illinois 60064. SuperGen and Abbott are referred to herein collectively as the "Parties" and individually as a "Party".
